Company Search:
Advanced Search
Sponsored Links
Progenics Pharmaceuticals, Inc. Company Snapshot
Progenics Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Progenics Pharmaceuticals with three other companies in this sector in UNITED STATES : Reliv' International, Inc. (2019 sales of $35.06 million ), Biofrontera AG (ADR) ($34.95 million of which 100% was Pharmaceuticals), and Dynavax Technologies Corporation ($35.22 million of which 100% was Biopharmaceutical Product).

Sales Analysis. Progenics Pharmaceuticals reported sales of $34.99 million for the year ending December of 2019. This represents an increase of 124.0% versus 2018, when the company's sales were $15.62 million.
  Stock Performance Chart for Progenics Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (6/19/2020): 4.10
(Figures in U.S. Dollars)
1 Week 1.5%   13 Weeks 3.5%  
4 Weeks 76.7%   52 Weeks -21.2%  
Progenics Pharmaceuticals, Inc. Key Data:
  Ticker: PGNX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 34,986,000
(Year Ending Jan 2020).
Employees: 105
  Currency: U.S. Dollars Market Cap: 355,043,600
  Fiscal Yr Ends: December Shares Outstanding: 86,596,000
  Share Type: Common Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.